Lifeward Reports First Quarter 2024 Financial Results Q1'24 revenue of $5.3M is up 340% vs. Q1'23 and at the midpoint of Lifeward's guidance range Newly established Medicare payment for ReWalk Personal Exoskeleton favorably impacts Q1'24 results Medicare Administrative Contractors ("MACs") approve 14 claims since fee schedule established MARLBOROUGH, MA, and YOKNEAM ILLIT, Israel, May 15, 2024 – ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global market leader delive ...